Nature Biotechnology
19, 209 - 211 (2001)
doi:10.1038/85631
Mapping a role for SNPs in drug developmentBonnie E. Gould Rothberg
Bonnie E. Gould Rothberg is group leader, pharmacogenomics at CuraGen Corporation, 555 Long Wharf Drive, New Haven, CT 06511
(bgould@curagen.com). Publication of the human genome SNP map is an early benchmark in efforts to increase the efficiency of drug development and improve the provision of medicine.
|
